Approved uses and off-label benefits Ozempic is U.S
Regulatory Snapshot (2025) Regulation around compounded GLP-1 therapy centers on two practical points: ingredient identity and shortage context
50 Grattan analysis of Department of Health, Disability, and Ageing (2026c), Department of Health, Disability, and Ageing (2025d), and Department of Health, Disability, and Ageing (2024e)
Always refer to the individual Summary of Product Characteristics (SmPC) and patient information leaflet for detailed, product-specific guidance on dosing, administration, storage, and missed doses
In contrast, freezing, although effective in preserving antioxidant activity and anti-proliferative effects, produced metabolic responses opposite to those observed with the fresh extract